Long-term effects of clenbuterol on diaphragm morphology and contractile properties in emphysematous hamsters.
The aim of the present study was to investigate the effect of chronic long-term clenbuterol treatment (1 mg/kg subcutaneously twice a day for 12 wk) on diaphragm morphology and function in emphysematous (EH) and normal hamsters (NH). Clenbuterol increased body weight, diaphragm weight, and skeletal muscle weight in both EH and NH to a similar extent. In the diaphragm, clenbuterol significantly increased myosin heavy chain type I, IIa, and IIx muscle fiber cross-sectional areas by approximately 35-55% in both EH and NH. This response to clenbuterol treatment was not significantly different between EH and NH diaphragm. In EH, twitch force (Pt), maximal tetanic force, and force-frequency curve were significantly reduced compared with NH. In EH, clenbuterol increased Pt by approximately 10%, restoring Pt to NH level. A similar improvement was observed in the force-frequency characteristics. Clenbuterol did not alter contractile properties in NH. In conclusion, long-term clenbuterol treatment resulted in an increased size of all diaphragm muscle fiber types in both NH and EH. Clenbuterol completely abolished the reduced force generation induced by emphysema.
Van Der Heijden
H F
HF
Department of Pulmonary Diseases, University Hospital Nijmegen, 6500 HB Nijmegen, The Netherlands.
Dekhuijzen
P N
PN
Folgering
H
H
Ginsel
L A
LA
Van Herwaarden
C L
CL
D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000818:Animals; D001835:Body Weight / Q000187:drug effects / Q000502:physiology; D002976:Clenbuterol / Q000494:pharmacology*; D006224:Cricetinae; D003964:Diaphragm / Q000254:growth & development / Q000473:pathology* / Q000503:physiopathology; D008297:Male; D008647:Mesocricetus; D009119:Muscle Contraction / Q000187:drug effects / Q000502:physiology; D024510:Muscle Development; D018485:Muscle Fibers, Skeletal / Q000187:drug effects / Q000502:physiology; D009929:Organ Size / Q000187:drug effects / Q000502:physiology; D011656:Pulmonary Emphysema / Q000473:pathology* / Q000503:physiopathology; D013997:Time Factors
D000318:Adrenergic beta-Agonists; D002976:Clenbuterol